Patient-Friendly Explanation
Metreleptin, sold under the brand name Myalept, is an injectable medication that replaces leptin — a hormone naturally produced by fat cells that signals the brain to regulate hunger and metabolism. It is specifically used for people with rare forms of lipodystrophy, a condition where the body cannot store fat properly. For these patients, metreleptin can dramatically improve metabolic health and help control appetite.
Clinical Definition
Metreleptin is a recombinant methionyl human leptin analogue indicated as an adjunct to diet for treating metabolic complications of leptin deficiency in patients with congenital or acquired generalised lipodystrophy. It binds to and activates the leptin receptor in the hypothalamus, restoring satiety signalling, improving insulin sensitivity, and reducing hyperphagia. Clinical trials demonstrated significant reductions in HbA1c (up to 2.2%), fasting triglycerides (up to 60%), and liver volume in treated patients.
Why It Matters
While metreleptin is reserved for specific rare conditions rather than general weight loss, it demonstrates the critical role of hormonal signalling in body weight regulation. At NuLifeCare, our doctors understand the full spectrum of weight-related hormonal conditions and can guide you toward the most appropriate treatment for your specific situation.